|
2021 Journal Article Meropenem versus piperacillin-tazobactam for definitive treatment of bloodstream infections caused by AmpC beta-lactamase producing Enterobacter spp., Citrobacter freundii, Morganella morganii, Providencia spp., or Serratia marcescens: a pilot multi-center randomized controlled trial (MERINO-2)Stewart, Adam G., Paterson, David L., Young, Barnaby, Lye, David C, Davis, Joshua S., Schneider, Kellie, Yilmaz, Mesut, Dinleyici, Rumeysa, Runnegar, Naomi, Henderson, Andrew, Archuleta, Sophia, Kalimuddin, Shirin, Forde, Brian M., Chatfield, Mark D., Bauer, Michelle J., Lipman, Jeffrey, Harris-Brown, Tiffany, Harris, Patrick N. A. and for the MERINO Trial Investigators and the Australasian Society for Infectious Disease Clinical Research Network (ASID-CRN) (2021). Meropenem versus piperacillin-tazobactam for definitive treatment of bloodstream infections caused by AmpC beta-lactamase producing Enterobacter spp., Citrobacter freundii, Morganella morganii, Providencia spp., or Serratia marcescens: a pilot multi-center randomized controlled trial (MERINO-2). Open Forum Infectious Diseases, 8 (8) ofab387, ofab387. doi: 10.1093/ofid/ofab387 |
|
2021 Journal Article Prolonged granulocyte transfusions sourced from buffy coats used to treat Aspergillus spp. infection in chronic granulomatous diseaseStewart, Adam G., Baidya, Shoma, Daly, James and Scott, Ashleigh P. (2021). Prolonged granulocyte transfusions sourced from buffy coats used to treat Aspergillus spp. infection in chronic granulomatous disease. Pathology, 54 (3), 358-361. doi: 10.1016/j.pathol.2021.05.098 |
|
2021 Journal Article In vitro activity of Cefotetan against ESBL-producing Escherichia coli and Klebsiella pneumoniae bloodstream isolates from the MERINO TrialStewart, Adam G., Cottrell, Kyra, Henderson, Andrew, Vemuri, Kanthi, Bauer, Michelle J., Paterson, David L. and Harris, Patrick N. A. (2021). In vitro activity of Cefotetan against ESBL-producing Escherichia coli and Klebsiella pneumoniae bloodstream isolates from the MERINO Trial. Microbiology Spectrum, 9 (1) e00226-21, 1-6. doi: 10.1128/spectrum.00226-21 |
|
2021 Journal Article New microbiological techniques for the diagnosis of bacterial infections and sepsis in ICU including point of carePeri, Anna Maria, Stewart, Adam, Hume, Anna, Irwin, Adam and Harris, Patrick N A (2021). New microbiological techniques for the diagnosis of bacterial infections and sepsis in ICU including point of care. Current Infectious Disease Reports, 23 (8) 12, 12. doi: 10.1007/s11908-021-00755-0 |
|
2021 Journal Article Completing the picture - capturing the resistome in antibiotic clinical trialsStewart, Adam G., Satlin, Michael J., Schlebusch, Sanmarié, Isler, Burcu, Forde, Brian M., Paterson, David L. and Harris, Patrick N. A. (2021). Completing the picture - capturing the resistome in antibiotic clinical trials. Clinical Infectious Diseases, 72 (12), e1122-e1129. doi: 10.1093/cid/ciaa1877 |
|
2021 Journal Article Listeria monocytogenes brain abscess as a late complication of allogeneic haemopoietic stem cell transplantationChung, Joseph, McCarthy, Kate L., Redmond, Andrew, Butler, Jason, Scott, Ashleigh P. and Stewart, Adam G. (2021). Listeria monocytogenes brain abscess as a late complication of allogeneic haemopoietic stem cell transplantation. Internal Medicine Journal, 51 (6), 1005-1006. doi: 10.1111/imj.15356 |
|
2021 Journal Article Molecular epidemiology of third-generation cephalosporin-resistant Enterobacteriaceae in Southeast Queensland, AustraliaStewart, A. G., Price, E. P., Schabacker, K., Birikmen, M., Harris, P. N. A., Choong, K., Subedi, S. and Sarovich, D. S. (2021). Molecular epidemiology of third-generation cephalosporin-resistant Enterobacteriaceae in Southeast Queensland, Australia. Antimicrobial Agents and Chemotherapy, 65 (6) e00130-21, 1-13. doi: 10.1128/AAC.00130-21 |
|
2021 Journal Article Just as good but better tolerated: posaconazole as first-line therapy for invasive aspergillosisStewart, Adam G. and Lane, Steven (2021). Just as good but better tolerated: posaconazole as first-line therapy for invasive aspergillosis. The Hematologist, 18 (3). |
|
2021 Journal Article How urgent is the need for new antifungals?Stewart, Adam G. and Paterson, David L. (2021). How urgent is the need for new antifungals?. Expert Opinion on Pharmacotherapy, 22 (14), 1-14. doi: 10.1080/14656566.2021.1935868 |
|
2021 Journal Article Infectious complications of CAR T-cell therapy: a clinical updateStewart, Adam G. and Henden, Andrea S. (2021). Infectious complications of CAR T-cell therapy: a clinical update. Therapeutic Advances in Infectious Disease, 8 204993612110367, 1-11. doi: 10.1177/20499361211036773 |
|
2020 Journal Article An update on cefepime and its future role in combination with novel β-lactamase inhibitors for MDR Enterobacterales and Pseudomonas aeruginosaIsler, Burcu, Harris, Patrick, Stewart, Adam G. and Paterson, David L. (2020). An update on cefepime and its future role in combination with novel β-lactamase inhibitors for MDR Enterobacterales and Pseudomonas aeruginosa. The Journal of Antimicrobial Chemotherapy, 76 (3), 550-560. doi: 10.1093/jac/dkaa511 |
|
2020 Journal Article Achromobacter infections and treatment optionsIsler, Burcu, Kidd, Timothy J., Stewart, Adam G., Harris, Patrick and Paterson, David L. (2020). Achromobacter infections and treatment options. Antimicrobial Agents and Chemotherapy, 64 (11) e01025, 1-16. doi: 10.1128/aac.01025-20 |
|
2020 Journal Article Is ceftazidime/avibactam an option for serious infections due to ESBL and AmpC producing Enterobacterales?: a systematic review and meta-analysisIsler, Burcu, Ezure, Yukiko, García-Fogeda Romero, Jose Luis, Harris, Patrick, Stewart, Adam G. and Paterson, David L. (2020). Is ceftazidime/avibactam an option for serious infections due to ESBL and AmpC producing Enterobacterales?: a systematic review and meta-analysis. Antimicrobial Agents and Chemotherapy, 65 (1) e01052-20. doi: 10.1128/AAC.01052-20 |
|
2020 Journal Article Whole genome sequencing for antimicrobial resistance mechanisms, virulence factors and clonality in invasive Streptococcus agalactiae blood culture isolates recovered in AustraliaStewart, Adam G., Burnard, Delaney, Sowden, David and McMillan, David (2020). Whole genome sequencing for antimicrobial resistance mechanisms, virulence factors and clonality in invasive Streptococcus agalactiae blood culture isolates recovered in Australia. Pathology, 52 (6), 694-699. doi: 10.1016/j.pathol.2020.06.006 |
|
2020 Journal Article Modern clinician-initiated clinical trials to determine optimal therapy for multi-drug resistant Gram-negative infectionsStewart, Adam G., Harris, Patrick N. A., Chatfield, Mark, Evans, Scott R., van Duin, David and Paterson, David L. (2020). Modern clinician-initiated clinical trials to determine optimal therapy for multi-drug resistant Gram-negative infections. Clinical Infectious Diseases, 71 (2), 433-439. doi: 10.1093/cid/ciz1132 |
|
2020 Journal Article Oral cephalosporin and β-lactamase inhibitor combinations for ESBL-producing Enterobacteriaceae urinary tract infectionsStewart, Adam G., Harris, Patrick N. A., Henderson, Andrew, Schembri, Mark A. and Paterson, David L. (2020). Oral cephalosporin and β-lactamase inhibitor combinations for ESBL-producing Enterobacteriaceae urinary tract infections. Journal of Antimicrobial Chemotherapy, 75 (9), 2384-2393. doi: 10.1093/jac/dkaa183 |
|
2020 Journal Article New treatment options for multiresistant gram negativesPaterson, David L., Isler, Burcu and Stewart, Adam (2020). New treatment options for multiresistant gram negatives. Current Opinion in Infectious Diseases, 33 (2), 214-223. doi: 10.1097/QCO.0000000000000627 |
|
2020 Journal Article Evaluation of quick sequential organ failure assessment and systemic inflammatory response syndrome in patients with gram negative bloodstream infectionMcNamara, John F., Avent, Minyon, Stewart, Adam, Kwan, Christopher and Paterson, David L. (2020). Evaluation of quick sequential organ failure assessment and systemic inflammatory response syndrome in patients with gram negative bloodstream infection. Infection, Disease and Health, 25 (3), 151-157. doi: 10.1016/j.idh.2020.01.003 |
|
2020 Conference Publication Molecular epidemiology and hospital spread of ceftriaxone non-susceptible enterobacterales in the Sunshine Coast region, AustraliaStewart, Adam, Sarovich, Derek, Price, Erin, Burnard, Delaney, Harris, Patrick, Choong, Keat and Subedi, Shradha (2020). Molecular epidemiology and hospital spread of ceftriaxone non-susceptible enterobacterales in the Sunshine Coast region, Australia. RACP Congress 2020: Balancing medical science with humanity, Online, May 2020. Richmond, VIC Australia: Wiley-Blackwell. doi: 10.1111/imj.4_14846 |
|
2020 Journal Article Initiating tuberculosis treatment at end of life – Balancing patient and infection control interestsStewart, Adam G. and Wright, Hugh (2020). Initiating tuberculosis treatment at end of life – Balancing patient and infection control interests. Infection, Disease and Health, 25 (4), 283-285. doi: 10.1016/j.idh.2020.05.009 |
